LBA
PTLA

Letko, Brosseau & Associates’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Letko, Brosseau & Associates’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-82,000
Closed -$1.48M – 105
2020
Q2 		$1.48M Buy
+82,000
New +$1.14M 0.02% 84

Letko, Brosseau & Associates's PTLA Position: Q3 2020 in Review

Letko, Brosseau & Associates sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 82,000 shares — an estimated $1.48M sold.

Letko, Brosseau & Associates first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $1.48M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Letko, Brosseau & Associates reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Letko, Brosseau & Associates sold 82,000 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.48M.
  • Letko, Brosseau & Associates first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Letko, Brosseau & Associates's Portola Pharmaceuticals, Inc. position peaked at $1.48M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Letko, Brosseau & Associates's 13F filing for Q3 2020, filed 9 Nov 2020.